col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

AMG Transcend Association: Biointerface Research in Applied Chemistry
  original article Date Title Authors   All Authors
1 [GO] 2021―Dec―31 HDR Degree Bassed Indices and Mhr-Polynomial for the Treatment of COVID-19
2 [GO] 2021―Dec―31 Synthesis and Identification of Novel Potential Thiadiazole Based Molecules Containing 1,2,3-triazole Moiety Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach
3 [GO] 2021―Dec―31 Effects of the Temperature and the pH on the Main Protease of SARS-CoV-2: A Molecular Dynamics Simulation Study
4 [GO] 2021―Dec―30 An Overview on Lambda, Epsilon, Kappa, Iota and Zeta Variants of Covid-19 and its Probability to Merge with Delta & Delta Plus, why it is a Concern
5 [GO] 2021―Dec―30 Delta Variant of Covid-19 Study, and Why it is a Concern: An Overview
6 [GO] 2021―Dec―30 Vaccine Design from the Microtubules Role in Coronavirus Entry and Exit: A Molecular Dynamic and Docking Simulation
7 [GO] 2021―Dec―30 Bioactive Compounds of Softwood Bark as Potential Agents against Human Diseases Include the SARS-CoV-2 Virus
8 [GO] 2021―Dec―30 Evaluation of the Inhibitory Activities of Ferula gummosa Bioactive Compounds against the Druggable Targets of SARS-CoV-2: Molecular Docking Simulation
9 [GO] 2021―Dec―29 Anti COVID-19 Drug - Potential Bioactive Compounds from Sprout Shoots of Curcuma longa Rhizome and Molecular Interaction Studies
10 [GO] 2021―Dec―29 Blocking Effect of Natural Alkaloids on COVID-19 Pentameric Ion Channel: An in silico Perspective
11 [GO] 2021―Dec―29 Investigation of the Effect of Comorbidity on Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis
12 [GO] 2021―Dec―29 In silico Prediction of Novel SARS-CoV 3CL pro Inhibitors: a Combination of 3D-QSAR, Molecular Docking, ADMET Prediction, and Molecular Dynamics Simulation
13 [GO] 2021―Dec―29 Improving the Inhibition of TMPRSS2 by Molecular Docking, to Decrease the Process Infection of SARS-CoV-2
14 [GO] 2021―Dec―29 Avoiding the Interaction between S-protein of SARS-CoV-2 and ACE2, to Develop an Adjuvant Antiviral by Molecular Docking
15 [GO] 2021―Dec―29 Molecular Docking and Molecular Dynamics Studies of SARS-CoV-2 Inhibitors: Crocin, Digitoxigenin, Beta-Eudesmol and Favipiravir: Comparative Study
16 [GO] 2021―Sep―01 Long Covid: A Review on Cardiovascular Disease (CVD) in Post-Acute Sequalae of SARS-CoV-2 Infection (PASC)
17 [GO] 2021―Sep―01 In silico Studies of Novel Synthetic Compounds as Potential Drugs to Inhibit Coronavirus (SARS-CoV-2): A Systematic Review
18 [GO] 2021―Aug―31 BCR-ABL Tyrosine Kinase Inhibitors as Candidates for the Treatment of COVID-19: Molecular Docking, Pharmacophore Modeling, ADMET Studies
19 [GO] 2021―Aug―31 Sequence Analysis and Structure Prediction of Malaysia SARS-CoV-2 Strain’s Structural and Accessory Proteins
20 [GO] 2021―Aug―26 A Mathematical Model to Expedite Electroporation Based Vaccine Development for COVID-19
21 [GO] 2021―Aug―21 Identification of Bioactive Phytoconstituents from the Plant Euphorbia hirta as Potential Inhibitor of SARS-CoV-2: an In-Silico Approach
22 [GO] 2021―May―04 Effect of Medicine on Interleukin-6 Inhibitors and their Forms Against COVID-19
23 [GO] 2021―May―04 Coronavirus Disease (COVID-19), Chemical Structure, Therapeutics, Drugs and Vaccines
24 [GO] 2021―May―04 Theoretical Investigation of some Antimalarial Sulfonamides as COVID-19 Drug Utilizing Computational Calculations and Molecular Docking Study
25 [GO] 2021―May―04 Thermal and Spectroscopic Studies of Some Prepared Metal Complexes and Investigation of their Potential Anticancer and Antiviral Drug Activity against SARS-CoV-2 by Molecular Docking Simulation
26 [GO] 2021―May―03 The Specification of Observed COVID-19 in England: A Review of Auto-Mutation
27 [GO] 2021―May―03 DFT Calculations and In silico Study of Chlorogenic, Ellagic and Quisqualic acids as Potential Inhibitors of SARS-CoV-2 Main Protease Mpro
28 [GO] 2021―May―03 Herbal Compounds from Syzygium aromaticum and Cassia acutifolia as a Shield against SARS-CoV-2 Mpro: a Molecular Docking Approach
29 [GO] 2021―May―03 SARS-COV-2 Spike Glycoprotein as Inhibitory Target for In silico Screening of Natural Compounds
30 [GO] 2021―May―01 In silico Approach on Ribavirin Inhibitors for COVID-19 Main Protease
31 [GO] 2021―May―01 Interacting Cubane Assisted Bi-Cytidine with COVID-19 Main Protease: In Silico Study
32 [GO] 2021―Feb―22 Photodynamic Therapy (PDT): An Alternative Approach for Combating COVID-19
33 [GO] 2021―Feb―22 Shogaol, Bisdemethoxycurcumin, and Curcuminoid: Potential Zingiber Compounds Against COVID-19
34 [GO] 2021―Feb―22 Domination, γ-Domination Topological Indices and φp -Polynomial of Some Chemical Structures Applied for the Treatment of COVID-19 Patients
35 [GO] 2021―Feb―22 Repurposing of Drugs Targeted Against COVID-19 Spike Receptor for Treatment: An In silico Approach
36 [GO] 2021―Feb―22 A Possible Destruction of SARS-CoV-2 by a Cylindrical Probe Coated with the Graphene Oxide: A Thermal-based Model
37 [GO] 2021―Feb―22 A New Proposed Mechanism of some Known Drugs Targeting the SARS-CoV-2 Spike Glycoprotein Using Molecular Docking
38 [GO] 2021―Feb―22 Molecular Docking Investigation of Antiviral Herbal Compounds as Potential Inhibitors of SARS-CoV-2 Spike Receptor
39 [GO] 2021―Jan―12 The Reduced Neighborhood Topological Indices and Polynomial for the Treatment of COVID-19
40 [GO] 2021―Jan―12 Utilizing Continuous Flow Microdevices-based Magnetophoresis for COVID-19 Diagnosis
41 [GO] 2021―Jan―12 Co-infection of Streptococcus pneumoniae in Respiratory Infections Caused by SARS-CoV-2
42 [GO] 2021―Jan―12 Piperaquine- and Aspirin- Mediated Protective Role of HSP70 and HSP90 as Modes to Strengthen the Natural Immunity against Potent SARS-CoV-2
43 [GO] 2021―Jan―12 In silico Investigation of Tridax procumbens Phyto-Constituents Against SARS-CoV-2 Infection
44 [GO] 2021―Jan―11 COVID-19 Case Fatality Ratio of Latino America Countries with Temperate Climate Partially Follows European and Oceania Trends According to Seasonal Change
45 [GO] 2021―Jan―11 An In Silico Screening on Piper nigrum, Syzygium aromaticum and Zingiber officinale roscoe Derived Compounds Against SARS-CoV-2: A Drug Repurposing Approach
46 [GO] 2020―Dec―27 Molecular Structure, Pathophysiology, and Diagnosis of COVID-19
47 [GO] 2020―Dec―27 Natural Product Emerging as Potential SARS Spike Glycoproteins-ACE2 Inhibitors to Combat COVID-19 Attributed by In-Silico Investigations
48 [GO] 2020―Dec―27 The Climate in the European Union and the Enlarged European Region is a Determinant of the COVID-19 Case Fatality Ratio
49 [GO] 2020―Dec―27 Potential COVID-19 Drug from Natural Phenolic Compounds through In Silico Virtual Screening Approach
50 [GO] 2020―Dec―27 Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers Usage in COVID-19 Illness Leading to Confusion or Conclusion: a Comprehensive Review
51 [GO] 2020―Dec―27 Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather?
52 [GO] 2020―Dec―27 Mutations in Novel COVID-19 Make it More Dangerous: Prevention Via Scientific Approaches
53 [GO] 2020―Dec―27 Variety of Spike Protein in COVID-19 Mutation: Stability, Effectiveness and Outbreak Rate as a Target for Vaccine and Therapeutic Development
54 [GO] 2020―Dec―27 Molecular Docking Evaluation of Some Indonesian’s Popular Herbals for a Possible COVID-19 Treatment
55 [GO] 2020―Dec―27 Nanomedicine for COVID-19: Potential of Copper Nanoparticles
56 [GO] 2020―Dec―27 Structural Perspective on Molecular Interaction of IgG and IgA with Spike and Envelope Proteins of SARS-CoV-2 and Its Implications to Non-Specific Immunity
57 [GO] 2020―Dec―27 Docking of FDA Approved Drugs Targeting NSP-16, N-Protein and Main Protease of SARS-CoV-2 as Dual Inhibitors
58 [GO] 2020―Dec―27 Potential Exploration of Recent FDA-Approved Anticancer Drugs Against Models of SARS-CoV-2’s Main Protease and Spike Glycoprotein: A Computational Study
59 [GO] 2020―Nov―08 Design and Synthesis of a 3,2′-Indane]-1′,3′-Dione Derivative and Their Theoretical Interaction with the Coronavirus Surface (COVID-19)
60 [GO] 2020―Nov―08 Does Living in Previously Exposed Malaria or Warm Areas is Associated with a Lower Risk of Severe COVID-19 Infection in Italy?
61 [GO] 2020―Nov―08 Role of Telemedicine and Telegenetics Framework for the Management of Cancer Patients During the COVID-19 Pandemic
62 [GO] 2020―Nov―08 Transcriptome and Coronavirus: New Hope and Therapy
63 [GO] 2020―Nov―08 A Bioinformatics Study of Structural Perturbation of 3CL-Protease and the HR2-Domain of SARS-CoV-2 Induced by Synergistic Interaction with Ivermectins
64 [GO] 2020―Aug―05 Contribution of Nanotechnology in the Fight Against COVID-19
65 [GO] 2020―Aug―05 Screening of Potent Inhibitors Against 2019 Novel Coronavirus (Covid-19) from Alliumsativum and Allium cepa: An In Silico Approach
66 [GO] 2020―Aug―05 Didemnins Inhibit COVID-19 Main Protease (Mpro)
67 [GO] 2020―Aug―05 Hydroxychloroquine Treatment may Benefit Nucleic Acid Testing of SARS-CoV-2 Turning Negative in Critically ill COVID-19 Patients: Report of 3 Cases
68 [GO] 2020―Aug―05 A Drug Repurposing Approach Towards Elucidating the Potential of Flavonoids as COVID-19 Spike Protein Inhibitors
69 [GO] 2020―Aug―05 Therapeutic Strategies of COVID-19: from Natural Compounds to Vaccine Trials
70 [GO] 2020―Aug―05 Molecular Docking Analysis of Phytochemical Thymoquinone as a Therapeutic Agent on SARS-Cov-2 Envelope Protein
71 [GO] 2020―Aug―03 Properties and Reactivities of Niclosamide in Different Media, a Potential Antiviral to Treatment of COVID-19 by Using DFT Calculations and Molecular Docking
72 [GO] 2020―Aug―03 Favipiravir May Acts as COVID-19 Main Protease PDB ID 6LU7 Inhibitor: Docking Analysis
73 [GO] 2020―Aug―03 A Review on COVID-19: Origin, Spread, Symptoms, Treatment, and Prevention
74 [GO] 2020―May―20 Evaluation of Coronavirus Families & Covid-19 Proteins: Molecular Modeling Study
75 [GO] 2020―May―20 Molecular Docking Studies of some Antiviral and Antimalarial Drugs Via Bindings to 3CL-Protease and Polymerase Enzymes of the Novel Coronavirus (SARS-CoV-2)
76 [GO] 2020―May―11 Design and synthesis of some imidazole derivatives: theoretical evaluation of interaction with a coronavirus (HCoV-NL63)
77 [GO] 2020―Mar―31 An overview on Coronaviruses family from past to Covid-19: introduce some inhibitors as antiviruses from Gillan’s plants


Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.005 sec